Real-time enrollment status for this extramedullary disease in multiple myeloma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 10:21 PM UTC
| NCT Number | NCT06627751 |
| Recruiting Status | Recruiting |
| Condition | Extramedullary Disease in Multiple Myeloma |
| Phase | PHASE2 |
| Target Enrollment | 28 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Roswell Park Cancer Institute |
| Last Updated on CT.gov | January 12, 2026 (Jan 12, 2026) |
As of July 19, 2026: Clinical trial NCT06627751 is currently recruiting participants. This phase2 study for extramedullary disease in multiple myeloma is actively seeking new participants at 1 location across the United States. The study is sponsored by Roswell Park Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06627751 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06627751 was last updated Jan 12, 2026 (January 12, 2026). HelloStudys verifies this status automatically.